Common Contracts
5 similar null contracts by Berkeley Lights, Inc., Impel Neuropharma Inc, Madison Square Garden Entertainment Corp., others
Madison Square Garden Entertainment Corp. 5,250,000 Shares of Common Stock Underwriting AgreementMadison Square Garden Entertainment Corp. • June 27th, 2023 • Services-miscellaneous amusement & recreation • New York
Sphere Entertainment Group, LLC, a Delaware limited liability company (the “Selling Stockholder”), a stockholder of Madison Square Garden Entertainment Corp., a Delaware corporation (the “Company”), proposes to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 5,250,000 shares of Class A common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 787,500 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
VERTIV HOLDINGS CO 20,000,000 Shares of Common Stock Underwriting AgreementVertiv Holdings Co • November 4th, 2021 • Electronic components, nec • New York
VPE Holdings, LLC (the “Selling Stockholder”) of Vertiv Holdings Co, a Delaware corporation (the “Company”), proposes to sell to J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Citigroup Global Markets Inc. (collectively, the “Underwriters”), an aggregate of 20,000,000 shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,000,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
Impel NeuroPharma, Inc. [●] Shares Common Stock ($0.001 par value) Underwriting AgreementImpel Neuropharma Inc • September 7th, 2021 • Pharmaceutical preparations • New York
Treace Medical Concepts, Inc. [●] Shares of Common Stock, par value $0.001 per share Underwriting AgreementTreace Medical Concepts, Inc. • April 19th, 2021 • Surgical & medical instruments & apparatus • New York
Treace Medical Concepts, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“J.P. Morgan”) and Morgan Stanley & Co. LLC (“Morgan Stanley”) are acting as representatives (the “Representatives”), an aggregate of [●] shares of common stock, par value $0.001 per share (“Common Stock”), of the Company, and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of [●] shares of Common Stock of the Company (collectively, the “Underwritten Shares”). In addition the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company, and the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (collectively, (the “Option S
BERKELEY LIGHTS, INC. [•] Shares of Common Stock Underwriting AgreementBerkeley Lights, Inc. • November 16th, 2020 • Laboratory analytical instruments • New York
Certain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Berkeley Lights, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.00005 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
